Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Prospective, Open-label Study for the Evaluation of the Selection and Outcome of the Antipsychotic Treatment Switch in Outpatients With Schizophrenia - ETOS Study

NCT00999895 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00999895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00999895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Prospective, Open-label Study for the Evaluation of the Selection and Outcome of the Antipsychotic Treatment Switch in Outpatients With Schizophrenia - ETOS Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
September 30, 2010
Enrollment
574 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia